Hims & Hers (Monday) $HIMS (+8.3%)

Axon Enterprise (Tuesday) $AXON (+2.93%)

Cava Group (Tuesday) $CAVA

Nvidia (Wednesday) $NVDA (-2.46%)

Salesforce (Wednesday) $CRM (-0.29%)

Zoetis (Thursday) $ZTS (+0.65%)

TransMedics (Thursday) $TMDX (-0.27%)

Monster Beverage (Thursday) $MNST (+0.36%)

Rocket Lab (Thursday) $RKLB (-1.85%)

Duolingo (Thursday) $DUOL

What do you expect from these companies?

Let's continue with the quarterly figures😬

among others

$NVDA (-2.46%)
$HIMS (+8.3%)
$HD (+0.7%)
$LOW (+1.35%)
$CRM (-0.29%)
$SNOW (+1.82%)
$VST (+0.8%)
$TMDX (-0.27%)
$O (+0.67%)
$STLAM (-1.27%)
$AXON (+2.93%)
$KDP (+0.03%)
$DOM (-0.32%)
$INTU (-0.37%)
$ZETA (-0.22%)

$TMDX (-0.27%)

I have decided to re-enter the market with one position and $NU (+0.29%) and reduce it slightly ✌️

Too many transplants on The Good Doctor (Netflix), that must be a signal 😁.

$TMDX (-0.27%)

TransMedics fell 14% today and is now approaching its worst fall ever 🧐

$TMDX (-0.27%)

TransMedics strongly rejects Scorpion Capital's short-seller report as unfounded and misleading. It emphasizes the role of the company's OCS technology in over 7,000 transplants and improved clinical outcomes - while focusing on next-generation product launches and strategic growth in 2025.

https://finance.yahoo.com/news/transmedics-responds-inaccurate-misleading-claims-120000397.html?guccounter=1&guce_referrer=aHR0cHM6Ly90LmNvLw&guce_referrer_sig=AQAAAH0wLD8u_IbrrDs2isGTqHmcRhh1Y4Iy6RTZPTVrLMpCzec4WyXOeEkWlXV8cQ7tZTfG3hyE8sH7C8CXl2umFqaMxh_XRfguA0BS8_BBuXl6HtnXpIrG-Sn9Ws2cwPF4t-pvefw7ewOHhAvc43ZYcS_LUvnE5rk0NgYdA4C6jBZu

$TMDX (-0.27%)

After careful consideration, I have decided to sell the small share $TMDX (-0.27%) until there is more clarity here. Above all, I also wanted to free up capital for possible additional purchases at $AMD (-1.82%) / $NU (+0.29%) / $IREN (-1.98%) to be able to make additional purchases.

Not that I necessarily believe in the correctness of the short report, but this situation makes it the easiest decision to liquidate my position.